| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Tyrosine-protein kinase ITK/TSK |
|---|
| Ligand | BDBM397215 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | Omnia Assay |
|---|
| IC50 | <10±n/a nM |
|---|
| Citation |  Singh, J; Petter, RC; Tester, RW; Kluge, AF; Mazdiyasni, H; Westlin, III, WF; Niu, D; Qiao, L Substituted 2,4-diaminopyrimidines as kinase inhibitors US Patent US9987276 Publication Date 6/5/2018 |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Tyrosine-protein kinase ITK/TSK |
|---|
| Name: | Tyrosine-protein kinase ITK/TSK |
|---|
| Synonyms: | EMT | ITK | ITK_HUMAN | Kinase EMT | LYK | T-cell-specific kinase | Tyrosine-protein kinase ITK | Tyrosine-protein kinase ITK (ITK) | Tyrosine-protein kinase Lyk |
|---|
| Type: | Protein |
|---|
| Mol. Mass.: | 71839.20 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | Q08881 |
|---|
| Residue: | 620 |
|---|
| Sequence: | MNNFILLEEQLIKKSQQKRRTSPSNFKVRFFVLTKASLAYFEDRHGKKRTLKGSIELSRI
KCVEIVKSDISIPCHYKYPFQVVHDNYLLYVFAPDRESRQRWVLALKEETRNNNSLVPKY
HPNFWMDGKWRCCSQLEKLATGCAQYDPTKNASKKPLPPTPEDNRRPLWEPEETVVIALY
DYQTNDPQELALRRNEEYCLLDSSEIHWWRVQDRNGHEGYVPSSYLVEKSPNNLETYEWY
NKSISRDKAEKLLLDTGKEGAFMVRDSRTAGTYTVSVFTKAVVSENNPCIKHYHIKETND
NPKRYYVAEKYVFDSIPLLINYHQHNGGGLVTRLRYPVCFGRQKAPVTAGLRYGKWVIDP
SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQ
LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIH
RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD
VWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPE
DRPAFSRLLRQLAEIAESGL
|
|
|
|---|
| BDBM397215 |
|---|
| n/a |
|---|
| Name | BDBM397215 |
|---|
| Synonyms: | US10596172, Compound I-160 | US10828300, Compound I-160 | US11351168, Compound I-160 | US9987276, Compound I-160 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C19H17FN6O3S |
|---|
| Mol. Mass. | 428.44 |
|---|
| SMILES | NS(=O)(=O)c1cccc(Nc2ncc(F)c(Nc3cccc(NC(=O)C=C)c3)n2)c1 |
|---|
| Structure | 
|
|---|
Search and Browse
